Cytokine Modulators

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Supply)
Duration
2 year (est.)
Value
£116M
Sector
HEALTH
Published
11 Feb 2021
Delivery
To 16 Feb 2023 (est.)
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 19 suppliers

2 buyers

11 suppliers

Description

Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice.

Lot Division

1 Etanercept

Supply of Etanercept to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to three (3) Framework Participants.
2 Infliximab IV

Supply of Infliximab IV to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
3 Infliximab Subcutaneous

Supply of Infliximab Subcutaneous to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.
4 Adalimumab

Supply of Adalimumab to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.
5 Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device

Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants.
6 Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes

Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
7 Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device

Supply of Methotrexate (25mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.
8 Methotrexate (25mg per 1 ml concentration ) pre-filled syringes

Supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.

Award Detail

1 Sandoz (Camberley)
  • Etanercept
  • Num offers: 3
  • Value: £46,271,726 [share]
  • Awarded to group of suppliers.
2 Pfizer (Tadworth)
  • Etanercept
  • Num offers: 3
  • Value: £46,271,726 [share]
  • Awarded to group of suppliers.
3 Biogen Idec (Maidenhead)
  • Etanercept
  • Num offers: 3
  • Value: £46,271,726 [share]
  • Awarded to group of suppliers.
4 Pfizer (Tadworth)
  • Infliximab IV
  • Num offers: 5
  • Value: £18,193,906 [share]
  • Awarded to group of suppliers.
5 Merck Sharp Dohme (Hoddesdon)
  • Infliximab IV
  • Num offers: 5
  • Value: £18,193,906 [share]
  • Awarded to group of suppliers.
6 Celltrion Healthcare (Slough)
  • Infliximab IV
  • Num offers: 5
  • Value: £18,193,906 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.
7 Biogen Idec (Maidenhead)
  • Infliximab IV
  • Num offers: 5
  • Value: £18,193,906 [share]
  • Awarded to group of suppliers.
8 Sandoz (Camberley)
  • Infliximab IV
  • Num offers: 5
  • Value: £18,193,906 [share]
  • Awarded to group of suppliers.
9 Celltrion Healthcare (Slough)
  • Infliximab Subcutaneous
  • Num offers: 1
  • Value: £307,680
  • Contractor is an SME.
10 Abbvie (Maidenhead)
  • Adalimumab
  • Num offers: 5
  • Value: £36,167,709 [share]
  • Awarded to group of suppliers.
11 Amgen (Cambrdige)
  • Adalimumab
  • Num offers: 5
  • Value: £36,167,709 [share]
  • Awarded to group of suppliers.
12 Fresenius Kabi (Runcorn)
  • Adalimumab
  • Num offers: 5
  • Value: £36,167,709 [share]
  • Awarded to group of suppliers.
13 Biogen Idec (Maidenhead)
  • Adalimumab
  • Num offers: 5
  • Value: £36,167,709 [share]
  • Awarded to group of suppliers.
14 Sandoz (Camberley)
  • Adalimumab
  • Num offers: 5
  • Value: £36,167,709 [share]
  • Awarded to group of suppliers.
15 Accord (Barnstaple)
  • Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device
  • Num offers: 2
  • Value: £14,775,961 [share]
  • Awarded to group of suppliers.
16 Medac Pharma (Stirling)
  • Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device
  • Num offers: 2
  • Value: £14,775,961 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.
17 Accord (Barnstaple)
  • Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes
  • Num offers: 1
  • Value: £390,136
18 Nordic Pharma (Theale)
  • Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device
  • Num offers: 1
  • Value: £218,102
  • Contractor is an SME.
19 Nordic Pharma (Theale)
  • Methotrexate (25mg per 1 ml concentration ) pre-filled syringes
  • Num offers: 1
  • Value: £317,995
  • Contractor is an SME.

Award Criteria

Supply Chain 5.0
PRICE 95.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated values referred to in Section II.I.5 and all Lots cover the initial twenty four (24) month duration and the maximum twenty four (24) month extension period. (SC Ref:642734)

Reference

Domains